Home / Orphenadrine, Combinations / Czechia
CZ ATC M03BC51 · updated 2 Nov 2026
Orphenadrine, Combinations shortage in Czechia
Is there an Orphenadrine, Combinations shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Orphenadrine, Combinations product is reported short in Czechia, the first since 17 Jun 2026. The company estimate for the return is 4 Dec 2026. Main reason: distribution or logistics.
Not reported short in any other country we track. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | NEODOLPASSE 75MG/30MG 75MG/30MG INF SOL 10X250ML | Fresenius Kabi s.r.o., Praha | 17 Jun 2026 | 4 Dec 2026 | Distribution or logistics Kapacitní/distribuční důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.